The LRIT3 gene helps the retina, the light sensing tissue at the back of the eye, pass visual signals from light detecting cells to the next step in the visual pathway. This gene plays an important role in helping your eyes adjust in dim light and form a clear visual signal. If the LRIT3 gene does not work properly, a person may have congenital stationary night blindness, with trouble seeing in the dark from early life. Some also have blurry vision, eye movements that are hard to control, or marked nearsightedness.
What is a gene?
Genes are pieces of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, the working parts of cells. Others mainly guide when certain processes happen, where they happen, and how strongly they take place. As a group, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in greater detail, you can learn more in the LearnHub.
Overview
LRIT3Gene function
What if the gene works
The LRIT3 gene helps the retina pass light signals from light sensing cells to nearby nerve cells. This supports vision in dim light and helps your eyes respond when lighting changes.
Risk
What if the gene does not work
Variants in the LRIT3 gene can cause congenital stationary night blindness, usually with difficulty seeing in dim light from birth. Milder to more severe variants may also influence visual sharpness and whether features like eye movement changes appear.
Treatment
What does that mean for your treatment
For pathogenic variants in the LRIT3 gene, no LRIT3-specific treatment or drug choice is currently established. The LRIT3 gene is being studied in inherited retinal disease research, including experimental gene replacement approaches in preclinical models.
Conditions associated with LRIT3
Gene function
What if the gene works
In the retina, the LRIT3 gene supports the handoff of light signals from one nerve cell to the next. This step helps the eye respond when light enters, whether you are walking outside or stepping into a dim room. Understanding how the LRIT3 gene works also helps explain how the retina sends light signals to the brain.
The LRIT3 gene helps relay signals triggered by light from photoreceptors to ON bipolar cells in the retina. This is a key early step in how the eye begins to process what you see.
Its protein sits at the meeting point between retinal cells and helps organize the signal passing machinery there. This keeps communication at the first visual connection orderly and efficient.
LRIT3 helps important partner proteins gather and stay in the right place for normal visual signaling. In everyday terms, it helps the eye's light response parts line up so messages move smoothly.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal differences among people, such as appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LRIT3 gene can reduce how much LRIT3 protein reaches the surface of retinal cells or change its shape, which disrupts how retinal cells pass light signals to the next cell. This is central to how LRIT3 gene variants affect retinal signaling, often through poor placement of TRPM1, a channel that helps a key group of retinal cells respond to light. Milder variants may leave some protein activity, while more disruptive variants can lead to little or no working protein and often more marked vision changes from early life.
How variants are linked to conditions
Variants in the LRIT3 gene cause complete congenital stationary night blindness, an inherited eye condition present from birth or early infancy. For people reading about LRIT3 gene variants and night blindness, this is the main well-established association. It often involves poor vision in dim light, reduced sharpness of vision, involuntary eye movements, crossed eyes, or nearsightedness. In most affected people, disease-causing variants are inherited in both copies of the gene.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For LRIT3, risk is mainly shaped by whether someone inherits disease-causing changes in both copies of the LRIT3 gene, which can lead to an inherited night vision condition. There is not strong evidence that lifestyle or environmental factors meaningfully increase or reduce this genetic risk.
Inheritance of LRIT3 variants
LRIT3-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops the condition only when they inherit two LRIT3 gene variants, one from each parent. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having a child with the condition, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child with neither variant. In practical terms, LRIT3 gene inheritance usually means the variant can pass quietly through a family until a child inherits both altered copies.
What does my LRIT3 result mean for my family?
For families with an LRIT3-related eye condition, the pattern is usually recessive. This means parents are often healthy carriers, and brothers or sisters may also be affected or may be carriers even if their vision seems typical. Other relatives may also carry the same gene change, especially on the parent’s side of the family.
Genetic information
Genetic testing
How you find out about variants
To find LRIT3 variants, doctors use a blood or saliva sample for LRIT3 genetic testing, often as part of a retinal disease panel or broader inherited vision loss test. The lab reads the DNA code and looks for variants in the LRIT3 gene that may help explain lifelong night blindness or other signs of congenital stationary night blindness.
When should I consider getting a genetic test?
Genetic testing for the LRIT3 gene may be worth considering if someone has had poor night vision since infancy or childhood, especially when eye testing suggests a lifelong form of night blindness. It can also help when this kind of inherited vision condition runs in the family or doctors are confirming the cause.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body works. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It looks at connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed and more personalized treatment decisions. If you want to learn more about this topic, you can read further in the LearnHub.
Drugs influenced by the LRIT3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so any concerns about side effects, new symptoms, or medication choices are best discussed with your doctor.